Clinical trials
Phase 3 Rhinitis, Allergic, Perennial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 15 |
| 2006 | 5 |
| 2007 | 3 |
| 2009 | 4 |
| 2010 | 8 |
| 2011 | 8 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 73 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 16 |
| Organon and Co | 11 |
| AstraZeneca | 7 |
| Sumitomo Pharma America, Inc. | 7 |
| Meda Pharmaceuticals | 3 |
| Sanofi | 3 |
| Tanabe Pharma Corporation | 3 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 3 |
| ALK-Abelló A/S | 2 |
| Boehringer Ingelheim | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhinitis, Allergic, Perennial | 80 |
| Rhinitis, Allergic | 18 |
| Rhinitis, Allergic, Seasonal | 13 |
| Hypersensitivity | 5 |
| Rhinitis | 5 |
| Dust Mite Allergy | 3 |
| Asthma | 1 |
| Conjunctivitis | 1 |
| Immune System Diseases | 1 |
| Nasal Obstruction | 1 |
Trials
Showing 26 to 50 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.